Clinical Trial Update: Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating telotristat ethyl for weight stability in advanced pancreatic cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Unresectable Pancreatic Adenocarcinoma

Drugs mentioned

• Telotristat Ethyl (telotristat ethyl)

Snippet

Sponsor: Emory University | Conditions: Locally Advanced Unresectable Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-12-16